Back to Results

RYojbaba Co Ltd (RYOJ)

rYojbaba Co., Ltd. is a Japan-based healthcare and consulting company listed on NASDAQ as common stock. The company operates through two business segments: Consulting Services and Health Services. Its consulting activities include labor and corporate advisory work for labor unions and companies, with support related to whistleblowing practices, stress checks, and dispute resolution between employers and labor groups. The Health Services segment provides care through osteopathic clinics and beauty salons, focusing on physical discomfort associated with work-related stress. Founded in 2015 and based in Fukuoka City, Japan, the company was previously known as Sakai Seikotsuin Co., Ltd. before adopting its current name in October 2021.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-RYOJ
$2.52
-30.8% Downside
Overvalued
Not available
Not available
Fair
0.0%
352.1x
6.9x
4.5x
42.042 M
44.978 M
17.4%
22.0%
5.9
576.6%
Valuation • Fair Value

rYojbaba Co Ltd (NASDAQ-RYOJ) Fair Value by Valuation Model

Review the available estimates for rYojbaba Co Ltd (NASDAQ-RYOJ), including DCF Fair Value, Ben Graham Formula Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$2.52

Estimated downside of 30.8% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$2.45

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0.11

Classic Ben Graham valuation formula reference.

Comps Fair Value

$2.56

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 5 available valuation references for rYojbaba Co Ltd (NASDAQ-RYOJ) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for rYojbaba Co Ltd (NASDAQ-RYOJ)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

9.336 M

Current operating scale indicator.

Revenue Forecast

9.336 M

Forward revenue estimate.

EBITDA

-59.921 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review rYojbaba Co Ltd (NASDAQ-RYOJ) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for rYojbaba Co Ltd (NASDAQ-RYOJ)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-3.16

No elevated caution signal from this screen.

Altman Z-Score

5.9

Relatively strong balance-sheet zone.

FCF / Net Income

576.6%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for rYojbaba Co Ltd (NASDAQ-RYOJ). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for rYojbaba Co Ltd (NASDAQ-RYOJ)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for rYojbaba Co Ltd (NASDAQ-RYOJ). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for rYojbaba Co Ltd (NASDAQ-RYOJ) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for rYojbaba Co Ltd (NASDAQ-RYOJ) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for rYojbaba Co Ltd (NASDAQ-RYOJ) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for rYojbaba Co Ltd (NASDAQ-RYOJ) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Buy

The monthly technical read for rYojbaba Co Ltd (NASDAQ-RYOJ) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

rYojbaba Co Ltd (NASDAQ-RYOJ) Stock FAQ

Data-supported answers about rYojbaba Co Ltd (NASDAQ-RYOJ), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$2.52
Estimated downside 30.8%
Valuation Rating
Overvalued
Estimated downside of 30.8%
Financial Health
Fair
Current financial-health read

The current fair value estimate for rYojbaba Co Ltd (NASDAQ-RYOJ) is $2.52. This implies an estimated downside of 30.8% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 30.8% versus the current market price.

The current financial health read for rYojbaba Co Ltd (NASDAQ-RYOJ) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for rYojbaba Co Ltd (NASDAQ-RYOJ).

The current P/E ratio listed for rYojbaba Co Ltd (NASDAQ-RYOJ) is 352.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for rYojbaba Co Ltd is 42.042 M.

The current enterprise value listed for rYojbaba Co Ltd is 44.978 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for rYojbaba Co Ltd is NASDAQ-RYOJ, and the stock is listed on NASDAQ.

rYojbaba Co Ltd (NASDAQ-RYOJ) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for rYojbaba Co Ltd is 17.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for rYojbaba Co Ltd is 22.0%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

UNH NYSE Unitedhealth Group Fair Value Fair Market Cap 338.3 B
CVS NYSE CVS Health Corp Fair Value Undervalued Market Cap 113.6 B
MCK NYSE McKesson Corporation Fair Value Undervalued Market Cap 102 B
HCA NYSE HCA Holdings Inc Fair Value Fair Market Cap 92.6 B
ELV NYSE Elevance Health Inc Fair Value Fair Market Cap 89.122 B
CI NYSE Cigna Corp Fair Value Bargain Market Cap 72.74 B
COR NYSE Cencora Inc Fair Value Undervalued Market Cap 58.924 B
CAH NYSE Cardinal Health Inc Fair Value Fair Market Cap 52.418 B
HUM NYSE Humana Inc Fair Value Fair Market Cap 46.377 B
CNC NYSE Centene Corp Fair Value Fair Market Cap 32.164 B
DGX NYSE Quest Diagnostics Incorporated Fair Value Fair Market Cap 27.202 B
LH NYSE Labcorp Holdings Inc Fair Value Fair Market Cap 26.01 B
GH NASDAQ Guardant Health Inc Fair Value Overvalued Market Cap 24.072 B
THC NYSE Tenet Healthcare Corporation Fair Value Fair Market Cap 21.095 B
EHC NYSE Encompass Health Corp Fair Value Fair Market Cap 12.011 B
BTSG NASDAQ Brightspring Health Services Inc Fair Value Fair Market Cap 11.838 B
FMS NYSE Fresenius Medical Care Corporation Fair Value Undervalued Market Cap 11.778 B
DVA NYSE DaVita HealthCare Partners Inc Fair Value Fair Market Cap 11.725 B
MOH NYSE Molina Healthcare Inc Fair Value Undervalued Market Cap 10.459 B
UHS NYSE Universal Health Services Inc Fair Value Undervalued Market Cap 10.413 B